ICON Public Limited Company

NASDAQ

Market Cap.

11.76B

Avg. Volume

1.57M

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about ICON Public Limited Company

ICON Public Limited Company News

ICON Public Limited Company Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock
Website screenshot
HealthcareMedical - Diagnostics & Research
iconplc.com

About ICON Public Limited Company

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including early development, patient recruitment and retention, strategy and analytics, late phase research, data and technology solution, and consulting and analytics services. The company's clinical development services also comprise medical imaging, clinical research and laboratory services, project management, site monitoring and management services, data management, biostatistics and programming, medical writing and publishing, medical affair, endpoint adjudication/data monitoring committees, pharmacovigilance, interactive response technologies, clinical supplies management, strategic regulatory, medical communication, and consulting and advisory services. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company was incorporated in 1990 and is headquartered in Dublin, Ireland.

ICON Public Limited Company Earnings & Revenue

What’s This Company Really Worth? Find Out Instantly.

Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.

ICON Public Limited Company Financials

Table Compare

Compare ICLR metrics with:

   

Earnings & Growth

ICLR

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

ICLR

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

ICLR

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

ICLR

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

ICON Public Limited Company Income

ICON Public Limited Company Balance Sheet

ICON Public Limited Company Cash Flow

ICON Public Limited Company Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsStrong Buy
Return on EquityBuy
Return on AssetsBuy
Debt/Equity RatioSell
Price/Earnings RatioSell
Price/Book RatioNeutral

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

ICON Public Limited Company Executives

NameRole
Dr. Steven A. Cutler MBA, Ph.D.Chief Executive Officer & Director
Mr. Nigel Clerkin A.C.A.Chief Financial Officer
Dr. John Climax Ph.D.Founder & Independent Non-Executive Director
Mr. Diarmaid CunninghamChief Administrative Officer, General Counsel & Company Secretary
Mr. Simon HolmesPresident of Corporate Investments & Partnerships
NameRoleGenderDate of BirthPay
Dr. Steven A. Cutler MBA, Ph.D.Chief Executive Officer & Director19601.69M
Mr. Nigel Clerkin A.C.A.Chief Financial OfficerMale1974762K
Dr. John Climax Ph.D.Founder & Independent Non-Executive Director195398K
Mr. Diarmaid CunninghamChief Administrative Officer, General Counsel & Company SecretaryMale1975

--

Mr. Simon HolmesPresident of Corporate Investments & PartnershipsMale1967

--

Discover More

Streamlined Academy

ICON Public Limited Company

NASDAQ

Market Cap.

11.76B

Avg. Volume

1.57M

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

ICON Public Limited Company News

ICON Public Limited Company Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock

ICON Public Limited Company Earnings & Revenue

ICON Public Limited Company Income

ICON Public Limited Company Balance Sheet

ICON Public Limited Company Cash Flow

ICON Public Limited Company Financials Over Time

ICON Public Limited Company Executives

NameRole
Dr. Steven A. Cutler MBA, Ph.D.Chief Executive Officer & Director
Mr. Nigel Clerkin A.C.A.Chief Financial Officer
Dr. John Climax Ph.D.Founder & Independent Non-Executive Director
Mr. Diarmaid CunninghamChief Administrative Officer, General Counsel & Company Secretary
Mr. Simon HolmesPresident of Corporate Investments & Partnerships
NameRoleGenderDate of BirthPay
Dr. Steven A. Cutler MBA, Ph.D.Chief Executive Officer & Director19601.69M
Mr. Nigel Clerkin A.C.A.Chief Financial OfficerMale1974762K
Dr. John Climax Ph.D.Founder & Independent Non-Executive Director195398K
Mr. Diarmaid CunninghamChief Administrative Officer, General Counsel & Company SecretaryMale1975

--

Mr. Simon HolmesPresident of Corporate Investments & PartnershipsMale1967

--

ICON Public Limited Company Insider Trades

No data available

DateNameRoleTransactionTypeShares

No data available

Streamlined Academy

Website screenshot
HealthcareMedical - Diagnostics & Research
iconplc.com

About ICON Public Limited Company

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including early development, patient recruitment and retention, strategy and analytics, late phase research, data and technology solution, and consulting and analytics services. The company's clinical development services also comprise medical imaging, clinical research and laboratory services, project management, site monitoring and management services, data management, biostatistics and programming, medical writing and publishing, medical affair, endpoint adjudication/data monitoring committees, pharmacovigilance, interactive response technologies, clinical supplies management, strategic regulatory, medical communication, and consulting and advisory services. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company was incorporated in 1990 and is headquartered in Dublin, Ireland.

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about ICON Public Limited Company

What’s This Company Really Worth? Find Out Instantly.

Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.

ICON Public Limited Company Financials

Table Compare

Compare ICLR metrics with:

   

Earnings & Growth

ICLR

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

ICLR

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

ICLR

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

ICLR

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsStrong Buy
Return on EquityBuy
Return on AssetsBuy
Debt/Equity RatioSell
Price/Earnings RatioSell
Price/Book RatioNeutral

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More

The Secret to Analyzing Winning Stocks (Step-by-Step Examples Inside)